Search engine for discovering works of Art, research articles, and books related to Art and Culture
ShareThis
Javascript must be enabled to continue!

Abstract 13673: Aging Impairs Cardiac Akt Activity Leading to Myocardial Sarcopenia

View through CrossRef
Introduction: Aging causes skeletal muscle atrophy (i.e. sarcopenia). In heart, aging is also known to cause cardiac dysfunction such as diastolic dysfunction; however, the impact of aging on myocardial cell growth remains uncertain. Hypothesis: Because of the pivotal role of protein kinase Akt in cellular aging and growth of cardiomyocytes, we hypothesized whether #1 aging may impairs cardiac Akt activation leading to myocardial atrophy in aged heart and #2 regular exercise may enhance cardiac Akt activity, leading to augmentation of cardiomyocyte growth that results in reversal of the aging-mediated cardiac atrophy. Methods: [cohort-1]: Male genetically senescence-accelerated [(SAM; senescence-accelerated prone (P10)] and senescence-resistant counterpart (R1) were allocated to EX [60-min running by treadmill/day for 6 months] and EX-free control (CON). [cohort-2] Male aged (40 w/o) and young (14 w/o) C57BL6 mice were subjected to the EX (agedC57EX and agedC57CON). Results: At baseline, cardiac geometry of R1 revealed normal, whereas P10 exhibited LV wall thinning and diastolic dysfunction. Systolic function of both P10 and R1 was preserved. After EX, body and heart weight (HW/BW) of R1 were increased (BW; +6.7% and HW; +3.5% versus R1CON); however, EX had no influence on HW/BW of P10. EX promoted LV hypertrophy in R1EX with concomitant increase in cardiac capillary density through activation of Akt/eNOS pathway, which was absent in P10EX. EX had no influence on systolic function of R1EX, however, EX promoted systolic dysfunction in P10EX [EF(%) 68.9±1.5 for P10EX versus 74.3±1.2 for P10CON] with attenuation of phosphorylated Akt and phospholamban levels in myocardium. In youngC57EX, EX promoted myocardial hypertrophy with augmentation of cardiac Akt/mTOR/S6K axis, which was diminished in agedC57EX. Age- and gender-matched Akt knockout mice exhibited lack of the EX-induced cardiac hypertrophy. Conclusions: Aging promotes cardiac sarcopenia in mice, in which Akt plays an essential role. EX-induced adaptive cardiac hypertrophy requires Akt activation and aging heart lacks the EX-induced Akt activation.
Title: Abstract 13673: Aging Impairs Cardiac Akt Activity Leading to Myocardial Sarcopenia
Description:
Introduction: Aging causes skeletal muscle atrophy (i.
e.
sarcopenia).
In heart, aging is also known to cause cardiac dysfunction such as diastolic dysfunction; however, the impact of aging on myocardial cell growth remains uncertain.
Hypothesis: Because of the pivotal role of protein kinase Akt in cellular aging and growth of cardiomyocytes, we hypothesized whether #1 aging may impairs cardiac Akt activation leading to myocardial atrophy in aged heart and #2 regular exercise may enhance cardiac Akt activity, leading to augmentation of cardiomyocyte growth that results in reversal of the aging-mediated cardiac atrophy.
Methods: [cohort-1]: Male genetically senescence-accelerated [(SAM; senescence-accelerated prone (P10)] and senescence-resistant counterpart (R1) were allocated to EX [60-min running by treadmill/day for 6 months] and EX-free control (CON).
[cohort-2] Male aged (40 w/o) and young (14 w/o) C57BL6 mice were subjected to the EX (agedC57EX and agedC57CON).
Results: At baseline, cardiac geometry of R1 revealed normal, whereas P10 exhibited LV wall thinning and diastolic dysfunction.
Systolic function of both P10 and R1 was preserved.
After EX, body and heart weight (HW/BW) of R1 were increased (BW; +6.
7% and HW; +3.
5% versus R1CON); however, EX had no influence on HW/BW of P10.
EX promoted LV hypertrophy in R1EX with concomitant increase in cardiac capillary density through activation of Akt/eNOS pathway, which was absent in P10EX.
EX had no influence on systolic function of R1EX, however, EX promoted systolic dysfunction in P10EX [EF(%) 68.
9±1.
5 for P10EX versus 74.
3±1.
2 for P10CON] with attenuation of phosphorylated Akt and phospholamban levels in myocardium.
In youngC57EX, EX promoted myocardial hypertrophy with augmentation of cardiac Akt/mTOR/S6K axis, which was diminished in agedC57EX.
Age- and gender-matched Akt knockout mice exhibited lack of the EX-induced cardiac hypertrophy.
Conclusions: Aging promotes cardiac sarcopenia in mice, in which Akt plays an essential role.
EX-induced adaptive cardiac hypertrophy requires Akt activation and aging heart lacks the EX-induced Akt activation.

Related Results

#986 Sarcopenia and chronic kidney disease among adults over 45 years old: findings from CHARLS
#986 Sarcopenia and chronic kidney disease among adults over 45 years old: findings from CHARLS
Abstract Background and Aims Little is known about the association between sarcopenia and chronic kidney disease (CKD) among Chi...
Sarcopenia is common in ulcerative colitis and correlates with disease activity
Sarcopenia is common in ulcerative colitis and correlates with disease activity
Background/Aims: Association of sarcopenia with disease severity in ulcerative colitis (UC) is not clearly defined. We planned to estimate the prevalence of sarcopenia in patients ...
Sarcopenia as a Predictor of Mortality and Complications in Cirrhosis Patients-A Prospective Cohort Study
Sarcopenia as a Predictor of Mortality and Complications in Cirrhosis Patients-A Prospective Cohort Study
<i>Background: </i>Sarcopenia has emerged as an important prognostic factor in cirrhosis patients. A standardized definition of sarcopenia was not used ...
Associations of body mass index and sarcopenia with screen-detected mild cognitive impairment in older adults in Colombia
Associations of body mass index and sarcopenia with screen-detected mild cognitive impairment in older adults in Colombia
Background and objectiveMore research is required to understand associations of body mass index (BMI) and sarcopenia with cognition, especially in Latin America. The objective of t...
The Frequency Of Sarcopenia In The Post-Covid Period And Its Relationship With The Clinical Course Of The Covid-19
The Frequency Of Sarcopenia In The Post-Covid Period And Its Relationship With The Clinical Course Of The Covid-19
Objectives:We planned this study and aimed to investigate the frequency of sarcopenia and the relationship between sarcopenia findings and Covid-19 disease severity in patients wit...
Biomarkers of sarcopenia: an unmet need
Biomarkers of sarcopenia: an unmet need
Abstract Background Sarcopenia is a syndrome characterized by a progressive decline in muscle mass and strength, with subsequent deterioration of fu...

Back to Top